Photopheresis: Therapeutic Potential in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.1, 2003-01, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucocorticoids in the Prevention of Restenosis After Coronary Angioplasty: Therapeutic Potential

By Ferrero Valeria Ribichini Flavio Pesarini Gabriele Brunelleschi Sandra Vassanelli Corrado

Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite

Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty

By Hamon M.

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite

Nucleic Acid Drugs for Preventing Restenosis after Coronary Revascularization

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1613-1620

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Oral Antiproliferative Agents in the Prevention of Coronary Restenosis

By Pramod Kuchulakanti Ron Waksman

Drugs, Vol. 64, Iss. 21, 2004-01 ,pp. : 2379-2388

Adis International

Access to resources Recommend Favorite

Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 613-618

Bentham Science Publishers

Access to resources Recommend Favorite